These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15001665)

  • 61. Eicosanoids in non-febrile thermoregulation.
    Aronoff DM; Romanovsky AA
    Prog Brain Res; 2007; 162():15-25. PubMed ID: 17645912
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.
    Kostenis E
    Pharmacol Ther; 2004 Jun; 102(3):243-57. PubMed ID: 15246248
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacology and action mechanism of prostaglandins and related substances as regulators of blood pressure].
    Miyazaki Y; Toki Y; Ito T
    Nihon Rinsho; 1992 Apr; 50 Suppl():90-6. PubMed ID: 1635268
    [No Abstract]   [Full Text] [Related]  

  • 64. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.
    Jenkinson DH; Barnard EA; Hoyer D; Humphrey PP; Leff P; Shankley NP
    Pharmacol Rev; 1995 Jun; 47(2):255-66. PubMed ID: 7568328
    [No Abstract]   [Full Text] [Related]  

  • 66. [Etiological significance of prostaglandins and related substances in hypertension].
    Omata K; Abe K
    Nihon Rinsho; 1992 Apr; 50 Suppl():309-17. PubMed ID: 1635208
    [No Abstract]   [Full Text] [Related]  

  • 67. Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates.
    Cossette C; Chourey S; Ye Q; Reddy CN; Wang R; Poulet S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    Eur J Pharm Sci; 2022 May; 172():106144. PubMed ID: 35158054
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Arachidonic acid cascade and signal transduction.
    Shimizu T; Wolfe LS
    J Neurochem; 1990 Jul; 55(1):1-15. PubMed ID: 2113081
    [TBL] [Abstract][Full Text] [Related]  

  • 69. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
    Vanhoutte PM; Barnard EA; Cosmides GJ; Humphrey PP; Spedding M; Godfraind T
    Pharmacol Rev; 1994 Jun; 46(2):111-6. PubMed ID: 7938161
    [No Abstract]   [Full Text] [Related]  

  • 70. International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.
    Clapham DE; Julius D; Montell C; Schultz G
    Pharmacol Rev; 2005 Dec; 57(4):427-50. PubMed ID: 16382100
    [No Abstract]   [Full Text] [Related]  

  • 71. Cloning and characterization of a family C orphan G-protein coupled receptor.
    Kuang D; Yao Y; Lam J; Tsushima RG; Hampson DR
    J Neurochem; 2005 Apr; 93(2):383-91. PubMed ID: 15816861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids.
    Pilane CM; Labelle EF
    J Cell Physiol; 2005 Aug; 204(2):423-7. PubMed ID: 15668944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
    Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
    Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
    [TBL] [Abstract][Full Text] [Related]  

  • 75. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels.
    Wei AD; Gutman GA; Aldrich R; Chandy KG; Grissmer S; Wulff H
    Pharmacol Rev; 2005 Dec; 57(4):463-72. PubMed ID: 16382103
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils.
    Monneret G; Boumiza R; Gravel S; Cossette C; Bienvenu J; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2005 Feb; 312(2):627-34. PubMed ID: 15388786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nomenclature and classification of transmitter receptors: an integrated approach.
    Hoyer D; Humphrey PP
    J Recept Signal Transduct Res; 1997; 17(1-3):551-68. PubMed ID: 9029515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.
    Neubig RR; Spedding M; Kenakin T; Christopoulos A;
    Pharmacol Rev; 2003 Dec; 55(4):597-606. PubMed ID: 14657418
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concise Syntheses of Microsomal Metabolites of a Potent OXE (Oxoeicosanoid) Receptor Antagonist.
    Chourey S; Wang R; Ye Q; Reddy CN; Sun S; Takenaka N; Powell WS; Rokach J
    Chem Pharm Bull (Tokyo); 2023; 71(7):534-544. PubMed ID: 37394602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.
    Lukas RJ; Changeux JP; Le Novère N; Albuquerque EX; Balfour DJ; Berg DK; Bertrand D; Chiappinelli VA; Clarke PB; Collins AC; Dani JA; Grady SR; Kellar KJ; Lindstrom JM; Marks MJ; Quik M; Taylor PW; Wonnacott S
    Pharmacol Rev; 1999 Jun; 51(2):397-401. PubMed ID: 10353988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.